e-Consultation with Haematologists

Professional statement

Dr Nina Salooja is one of London's leading haematologists. She is an NHS consultant at Imperial NHS trust based at the Hammersmith site and is also an adjunct Associate Professor / Reader to the faculty of medicine, Imperial College. She is a specialist in general haematology conditions including diagnosis and management of anaemia, neutropenia, thrombocytopenia, thrombocytosis, iron overload (including haemochromatosis) and iron deficiency. She is also an expert in thrombosis and haemostasis (blood clots and bleeding disorders), in particular deep vein thrombosis and pulmonary embolism. She has an additional specialist interest in the long term complications of stem cell transplantation. Dr Salooja graduated from Oxford University in 1983 and completed her clinical training from St Thomas's hospital in 1986. Subsequently she held research fellowships with the Leukemia Research Fund (LRF) and also the Medical Research council (MRC). She is a fellow of both the Royal College of Physicians and the Royal College of Pathologists. Dr Salooja has held multiple leadership roles locally, regionally and internationally. She has published more than one hundred peer-reviewed articles, chapters and printed abstracts and her work is widely cited. She has contributed significantly to collaborative International guideline development with colleagues in Europe and the USA. Dr Salooja is passionate about education. She is a fellow of the higher education academy and has a Masters degree in Education. She has won prizes for her teaching and held multiple leadership roles in education both at a University level and within NHS England.

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr Santhosh Narat is an esteemed haematologist based at Worthing and Sussex NHS Foundation Trust Hospital. Working across hospitals in London and Sussex, Dr Narat's main areas of clinical interest are haematological oncology (myeloma, lymphoma, leukemia), general haematology (anaemia, white cell, platelet disorders), thrombosis and bleeding disorders, thrombophilia screening, bood transfusions, and venesections for haemochromatosis. Dr Narat completed his specialist training in Haematology in the UK in the North London hospitals such as St Mary's, the Royal Free and Hammersmith and has been working as a consultant in the NHS since 2005. On top of his clinical commitments he is responsible for Specialist Registrar training and  mentoring junior doctors and haematological specialist nurses in an educational and clinical supervisory role .He is also the principal investigator conducting a number of NHS-run clinical trials researching haematological malignancies, helping to make advances in his field. He provides cutting edge treatment to his patients and keeps abreast of changes by regularly attending national and international Haematology conferences and regular annual appraisals. He is the recipient of a Clinical Excellence Award from the WSH NHS Foundation Trust.

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr David Wrench is a consultant haematologist with expertise in all areas of his field, particularly in the diagnosis and treatment of blood cancers and lymphoma. His range of specialist knowledge includes lymphomas, non-Hodgkin's lymphoma, Hodgkin's disease, low blood count, anaemia and lymphadenopathy. After completing his studies in medicine at Cambridge University, Dr Wrench specialised in haematology and received his training at numerous esteemed London hospitals. He attends private patients at London Bridge Hospital and at Guy's and St Thomas' Private Healthcare. As well as this, he works within the NHS at the Guy's and St Thomas' NHS Foundation Trust. During his PhD at Barts Cancer Institue, Dr Wrench published lead scientific papers in lymphoma. His research interests involve novel therapies and the aggressive transformation of lymphoma, as well as haematological malignancies and the rapid diagnosis of lumps. 

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr Sunil Gupta is a consultant haematologist and haem-oncologist with over 25 years of experience in clinical and laboratory haematology, spanning four countries. He specialises in haematology-oncology, clotting disorders, anaemia, myeloproliferative disorders, immune thrombocytopenic purpura and bleeding disorders. Dr Gupta has been trained by some of the best institutes in the world, namely King's College Hospital, London; Royal North Shore Hospital, Sydney; National University Hospital (NUH), Singapore and the All Institute of Medical Sciences (AIIMS) New Delhi, India. He obtained his Certificate of Completion of Specialty Training (CCST) from London Deanery at King's College Hospital. He undertook clinical research in anthracycline toxicity in children suffering from acute lymphoblastic leukaemia. Dr Gupta is the Clinical Director for Haematology and Cancer at Lewisham and Greenwich NHS hospital. He is the principal investigator of TACTIC CoVID trial.  Dr Gupta is an avid researcher. He is the lead for research and development (R&D) in haematology at Lewisham and Greenwich NHS Trust (LGT) and opened several new clinical drug trials in haem-oncology. He has been Principal Investigator of more than 10 national and commercial clinical trials and Dr Gupta has remained involved in new drugs appraisal for NICE (The National Institute for Health and Care Excellence). He has many publications to his credit and is also a member of the Sounding Board of British Society for Haematology (BSH). Dr Gupta has a deep interest in teaching and was awarded the title of Honorary Senior Clinical Lecturer by GKT School of Medicine. He is currently cancer and genetics lead for year 3 medical students at LGT. He is also career guidance lead (Career Champion) in haematology for LGT. Dr Gupta is also a trained and certified appraiser and CPD advisor to the Federation of the Royal Colleges of Physicians.  Dr Gupta provides in-patient and outpatient chemotherapies for multiple myeloma, lymphomas, chronic lymphocytic leukaemia, chronic myeloid leukaemia, and myeloproliferative disorders. He also offers day-case and in-patient blood transfusion and iron infusion. Dr Gupta is on the panel of all the major insurance providers. Dr Gupta is a fitness freak. He bears a holistic approach towards health. He is a trained and certified Yoga instructor and runs his weekly classes in Bromley for free to boost the health in the community.

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr Muhsin Almusawy is a Clinical Lead Consultant haematologist in Bedford who diagnoses and treats all blood diseases, including all types of anaemia, red blood cell disorders and all types of blood and bone marrow cancers. He has experience in all aspects of malignant and non-malignant haematology and their management, including haemostasis and thrombosis with a lot of experience in the new anticoagulant drugs. Dr Almusawy studied and trained for his postgraduate in medicine in Scandinavia before moving to the UK where he has been on the specialist register as a consultant since 2008. He spent a number of years working and training in many different hospitals in the UK, including the Manchester Royal Infirmary, Hammersmith Hospital in London and at the Bristol Haematology and Oncology Centre. Dr Almusawy is the Lead Consultant for haematology services at Bedford Hospital. He acts as the Chair of the Haemostasis and Thrombosis committee. Dr Almusawy is the Principal Investigator on two national and international research projects.

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr Varun Mehra is a leading Consultant Haematologist based in London who specialises in myelodysplastic syndrome, acute leukaemia, autologous transplantation for autoimmune conditions such as multiple sclerosis, Crohn's disease, systemic sclerosis, etc, allogeneic stem cell transplantation, immunotherapy and post-transplant complications. Dr Mehra completed his post-graduate specialist Haematology training at world renowned Kings College Hospital, London, where he has been working for past few years as a core member of a busy Stem Cell Transplant & Cellular therapy unit, while pursuing his MD (res) Degree with Kings College London University in developing novel diagnostic biomarkers for invasive fungal disease (aspergillosis) in immunocompromised Haemato-oncology patients. He has been instrumental in leading a large single centre NRCN badged prospective study on Invasive Fungal disease and has a good track record for his involvement in Clinical Trials, more recently as Lead Chief Investigator and Principal Investigator of various infection and transplant related ATMP and Non-ATMP Clinical Trials in the UK. He has regularly presented in key regional, national and international meetings as invited Speaker as well as Faculty member in field of Mycology and Stem Cell Transplantation. He is an active Member of EBMT Autoimmune and Infectious disease working party and Member of EORTC advisory group on Infections and Leukaemia. Dr Mehra's main research interests are in infections of immunocompromised hosts, graft versus host disease, transplantation of autoimmune diseases including cellular therapy strategies; and have helped develop exciting collaborations in Infection research & education within and outside Kings Health Partners with bench to bed translation opportunities. He has published regularly on his disease specific research interests in high impact clinical and scientific journals. He has been active in developing educational pathways and trainee mentorship programmes within haemato-pathology training in London. He previously chaired London School of Pathology Specialist Trainee Committee and represented London Pathology Trainees in the Royal College Specialist Advisory group between 2014-2016. He is currently the Education Lead for King’s Haematology Training program. He currently sits on the KHP Institute of Haematology Education & Training steering group, playing an active role in developing post-graduation modules for training in clinical haematology and other disease specific Preceptorship training programs.  Dr Mehra is also fully trained in the assessment of patients for, and delivery of CAR-T therapy, a highly specialized new therapy that has recently been licensed for certain patients with relapsed high grade B cell lymphomas and acute lymphoblastic leukaemia. 

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr Salim Shafeek is an expert haematologist and haemato-oncologist in the West Midlands region in Edgbaston, Worcester and Droitwich, who holds a special interest in lymphoma and myeloma. He treats general haematology, including haemato-oncology, thrombosis-haemostasis, red cell disorders and acute and chronic leukaemia. Dr Shafeek trained in haemato-oncology in the West Midlands regional rotation at the Queen Elizabeth Hospital, Birmingham Heartlands Hospital, Birmingham Children’s Hospital, Birmingham City Hospital and the University Hospital Coventry and Warwick from 1995 until 2001. He is currently the Clinical Director for the Worcestershire Acute NHS Trust and is actively involved in the restructuring of the cancer network in the county. Dr Shafeek teaches both undergraduates and postgraduates through the University of Birmingham and is an examiner for the MRCP (UK) Royal College of Physicians London, Edinburgh and Glasgow. He has close links with the Cure Leukaemia Charity and is involved in fundraising activities and fundraising for Breast Cancer unit in Worcester.

*Translated with Google translator. We apologize for any imperfection